DECISION-ANALYSIS OF HEMATOPOIETIC GROWTH-FACTOR USE IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY

被引：5

作者：

MAYORDOMO, JI ^{[1
]}

RIVERA, F ^{[1
]}

DIAZPUENTE, MT ^{[1
]}

LIANES, P ^{[1
]}

CORTESFUNES, H ^{[1
]}

机构：

[1] TWELVE OCTUBRE UNIV HOSP,DIV MED ONCOL,MADRID,SPAIN

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1993年 / 85卷 / 15期

关键词：

D O I：

10.1093/jnci/85.15.1251-a

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1251 / 1252

页数：2

共 50 条

[41] HEMATOPOIETIC CYTOKINES INHIBIT APOPTOSIS INDUCED BY TRANSFORMING GROWTH FACTOR-BETA-1 AND CANCER-CHEMOTHERAPY COMPOUNDS IN MYELOID LEUKEMIC-CELLS
LOTEM, J
SACHS, L
BLOOD, 1992, 80 (07) : 1750 - 1757
[42] GROWTH-FACTOR EXPRESSION AS A POTENTIAL SURVIVAL PROGNOSTICATOR IN PATIENTS WITH ESOPHAGEAL ADENOCARCINOMA RECEIVING HIGH-DOSE RADIATION AND CHEMOTHERAPY
SAUTER, E
COLA, L
EISENBERG, B
HANKS, G
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 : 214 - 215
[43] INFORMAL DECISION-ANALYSIS AND TREATMENT CHOICE BY BREAST-CANCER PATIENTS
ASHCROFT, J
OWENS, RG
LEINSTER, SJ
BULLETIN OF THE BRITISH PSYCHOLOGICAL SOCIETY, 1985, 38 (MAY): : A53 - A54
[44] Use of Supplements by Japanese Cancer Patients Receiving Outpatient Cancer Chemotherapy
Aoshima, Emi
Mibu, Marie
Kubota, Masaru
Hashida, Tohru
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2018, 24 (9-10) : 1003 - 1006
[45] DECREASED COSTS IN CANCER-CHEMOTHERAPY PATIENTS USING RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR
GLASPY, JA
BLEECKER, GC
CRAWFORD, J
STOLLER, RG
STRAUSS, MJ
CLINICAL RESEARCH, 1991, 39 (01): : A7 - A7
[46] CORRELATIONS BETWEEN WHITE BLOOD-COUNT AND ABSOLUTE GRANULOCYTE COUNT IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY
BENSON, AB
KOELLER, JM
GOEBEL, SL
ROSENBAUM, PR
TORMEY, DC
CLINICAL RESEARCH, 1983, 31 (04): : A741 - A741
[47] THE USE OF HEMATOPOIETIC GROWTH-FACTORS TO SUPPORT CYTOTOXIC CHEMOTHERAPY FOR PATIENTS WITH BREAST-CANCER
DEMETRI, GD
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1994, 8 (01) : 233 - 249
[48] EVALUATION OF THE EFFICACY OF A NOVEL DIET IN CONTROLLING ANOREXIA AND IMPROVING QUALITY OF LIFE IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY
ACKLAND, S
ODELLI, C
ADAM, S
FORBES, J
PROCEEDINGS OF THE NUTRITION SOCIETY OF AUSTRALIA, VOL 14, 1989, : 98 - 98
[49] RELATIONSHIP OF ORAL COMPLICATIONS TO PERIPHERAL-BLOOD LEUKOCYTE AND PLATELET COUNTS IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY
LOCKHART, PB
SONIS, ST
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1979, 48 (01): : 21 - 28
[50] PRONOUNCED ANTI-EMETIC ACTIVITY OF THE ANTIPSYCHOTIC DRUG LEVOMEPROMACINE (L) IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY
HIGI, M
NIEDERLE, N
BIERBAUM, W
SCHMIDT, CG
SEEBER, S
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1980, 97 (01) : 81 - 86

← 1 2 3 4 5 →